Insider · CIK 0001313876

RICHMAN ERIC I

Reports to the SEC for 5 companies · ANNAPOLIS, MD

sec.gov

Transactions

Companies

Filings

CIK

0001313876

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-06-24	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-07-01	GANXGain Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$1.23	+$6,150	277,629
2024-07-01	GANXGain Therapeutics, Inc.P Purchase	Director	PPurchase	+12K sh	$1.21	+$14.5K	289,629
2024-06-24	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-09-20	GANXGain Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+54.9K sh	—	—	272,629
2023-09-20	GANXGain Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−54.9K sh	—	—	0
2022-09-20	GANXGain Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+329K sh	—	—	329,400
2022-09-20	GANXGain Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+54.9K sh	—	—	54,900
2022-09-09	NeuBase Therapeutics, Inc.Stock option (right to buy)A Award	Director	AAward	+37.6K sh	—	—	37,600
2022-05-25	GANXGain Therapeutics, Inc.P Purchase	Director	PPurchase	+2,482 sh	$2.58	+$6,403.56	217,729
2022-05-20	GANXGain Therapeutics, Inc.P Purchase	Director	PPurchase	+9,256 sh	$2.83	+$26.2K	215,247
2022-05-19	GANXGain Therapeutics, Inc.P Purchase	Director	PPurchase	+4,000 sh	$2.71	+$10.8K	205,991
2022-03-04	NeuBase Therapeutics, Inc.P Purchase	Director	PPurchase	+1,000 sh	$1.62	+$1,620	44,960
2022-03-03	NeuBase Therapeutics, Inc.P Purchase	Director	PPurchase	+1,300 sh	$1.72	+$2,236	43,960
2022-03-01	NeuBase Therapeutics, Inc.P Purchase	Director	PPurchase	+1,580 sh	$1.58	+$2,496.4	42,660
2021-08-19	NeuBase Therapeutics, Inc.Stock option (right to buy)A Award	Director	AAward	+38.1K sh	—	—	38,135
2021-08-16	GANXGain Therapeutics, Inc.P Purchase	Director	PPurchase	+4,922 sh	$7.87	+$38.7K	216,820
2021-08-16	GANXGain Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,922 sh	$7.87	+$38.7K	216,820
2021-04-26	NeuBase Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$5.00	+$25K	41,080
2020-09-09	NeuBase Therapeutics, Inc.Stock option (right to buy)A Award	Director	AAward	+14.6K sh	—	—	14,634
2020-04-30	NeuBase Therapeutics, Inc.P Purchase	Director	PPurchase	+2,500 sh	$6.00	+$15K	27,747
2020-04-30	NeuBase Therapeutics, Inc.P Purchase	Director	PPurchase	+8,333 sh	$6.00	+$50K	36,080
2020-02-28	ADMAADMA BIOLOGICS, INC.A Award	Director	AAward	+7,500 sh	—	—	44,030
2020-02-28	ADMAADMA BIOLOGICS, INC. · Employee Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-07-12	NeuBase Therapeutics, Inc.A Award	Director	AAward	+25.2K sh	—	—	25,247
2019-07-12	NeuBase Therapeutics, Inc.Stock option (right to buy)A Award	Director	AAward	+227K sh	—	—	227,330
2019-03-13	ADMAADMA BIOLOGICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2018-06-22	ADMAADMA BIOLOGICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2018-06-08	ADMAADMA BIOLOGICS, INC.P Purchase	Director	PPurchase	+5,230 sh	$4.78	+$25K	36,530
2017-11-09	ADMAADMA BIOLOGICS, INC.P Purchase	Director	PPurchase	+25K sh	$2.15	+$53.8K	31,300
2017-07-13	ADMAADMA BIOLOGICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,800 sh	$2.68	+$7,504	6,300
2017-07-13	ADMAADMA BIOLOGICS, INC. · Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,800 sh	—	—	0
2017-06-06	ADMAADMA BIOLOGICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+78.1K sh	—	—	78,144
2017-02-14	ADMAADMA BIOLOGICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+30.6K sh	$2.46	+$75.2K	444,895
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+37.5K sh	$1.19	+$44.6K	482,395
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+240K sh	$1.94	+$466K	722,395
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+136K sh	$1.71	+$232K	858,055
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$1.69	+$33.8K	878,055
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$2.20	+$44K	898,055
2016-11-22	ALTAltimmune, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30.6K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−37.5K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−240K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−136K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2016-09-28	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+100K sh	$1.51	+$151K	276,822
2016-09-28	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+100K sh	$1.48	+$148K	376,822
2016-09-28	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+37.5K sh	$1.19	+$44.6K	414,322
2016-09-28	ALTAltimmune, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−100K sh	—	—	0

Recent filings

Accepted (ET)
Jun 254
RICHMAN ERIC I0001641172-25-016537
SEC(opens sec.gov)
Jul 14
RICHMAN ERIC I0001493152-24-025831
SEC(opens sec.gov)
Jun 264
RICHMAN ERIC I0001493152-24-025335
SEC(opens sec.gov)
Sep 224
RICHMAN ERIC I0001209191-23-050380
SEC(opens sec.gov)
Sep 224
RICHMAN ERIC I0001209191-22-051014
SEC(opens sec.gov)
Sep 124
RICHMAN ERIC I0001104659-22-099290
SEC(opens sec.gov)
May 274
RICHMAN ERIC I0001415889-22-005798
SEC(opens sec.gov)
May 234
RICHMAN ERIC I0001415889-22-005501
SEC(opens sec.gov)
Apr 214/A
RICHMAN ERIC I0001209191-22-025180
SEC(opens sec.gov)
Mar 74
RICHMAN ERIC I0001104659-22-031172
SEC(opens sec.gov)
Sep 174
RICHMAN ERIC I0001104659-21-116920
SEC(opens sec.gov)
Aug 174
RICHMAN ERIC I0001104659-21-107121
SEC(opens sec.gov)
Apr 274
RICHMAN ERIC I0001104659-21-055582
SEC(opens sec.gov)
Sep 114
RICHMAN ERIC I0001104659-20-104489
SEC(opens sec.gov)

Companies

Address

C/O PHARMATHENE, INC. ONE PARK PLACE, SUITE 450

ANNAPOLIS, MD, 21401